Quantitative MRI for monitoring metabolic dysfunction associated steatotic liver disease: A test-retest repeatability study

This study demonstrates the accuracy and reproducibility of LiverMultiScan metrics (cT1 and PDFF) in patients with MASH and MASLD. The results quantify the minimal detectable (absolute) changes in cT1 (32 ms) and liver fat fraction (0.6%) that discern measurement error from real change when monitoring patients with MASLD on a single scanner.